Skip to main content

MeiraGTx Holdings plc

corporate_fare Company Profile

MeiraGTx Holdings plc

MGTX·NASDAQ·Life Sciences·CIK 0001735438

We are a vertically integrated, clinical-stage genetic medicines company. We have a broad pipeline of late-stage clinical programs, including treatments for radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. Our clinical programs use targeted local delivery of small doses of genetic medicines to treat both inherited and more common conditions with severe unmet need. Our internal end-to-end manufacturing capabilities support the development of our clinical pipeline. We operate two viral vector production facilities for good manufacturing practices (GMP), internal plasmid production for GMP, and an in-house Quality Control hub for stability and release. These facilities are suitable for Investigational New Drug application (IND) through commercial supply. We have also developed a proprietary manufacturing platform with industry-leading yield and quality aspects and commercial readiness. Our core capabilities in viral vector and capsid optimization enable increased potency, decreased dose, and significantly reduced cost of goods for our genetic medicines. We have developed a transformative gene regulation platform using bespoke synthetic riboswitch technology invented in-house. This technology allows for the precise, dose-responsive expression of any transgene under the control of oral small molecules. We are focusing the riboswitch platform on the in vivo delivery of biologic therapeutics such as the metabolic peptides glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), glucagon, amylin, peptide YY (PYY), and leptin via oral small molecules. We are also applying it to cell therapy for oncology and autoimmune diseases, and long term intractable pain. We have developed unique comprehensive technology capabilities to apply genetic medicine to more prevalent diseases, increasing efficacy, addressing novel targets, and expanding access in some of the largest disease areas where the unmet need remains high. We own and operate manufacturing facilities in London, United Kingdom and Shannon, Ireland.

MeiraGTx Holdings plc (NASDAQ:MGTX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 25 items for MGTX at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 16 rated 8 or above. Recent SEC coverage for MGTX spans 10-Q, 8-K, DEF 14A, SCHEDULE 13D/A.

Recent high-impact activity:

  • MeiraGTx Narrows Q3 Loss to $51.3M as Bota-Vec Filing Nears
  • MeiraGTx Q2 2026: $160.7M Profit, Cash Runway to H2 2028, Oberland Capital Deal Details
  • MeiraGTx Q2 2026: $160.7M Net Income, Bota-vec Acquisition, and FDA Breakthrough Designation
  • MeiraGTx Swings to $160.7M Q2 Profit, Acquires Bota-vec, and Secures FDA Breakthrough Designation
  • MeiraGTx's GV101 Gets FDA Clearance to Enter Phase 2 for Friedreich's Ataxia

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$81.39M
Net Income
-$114.2M
Diluted EPS
-$1.42
Op. Cash Flow
-$46.36M
Free Cash Flow
-$50.19M
Operating Income
-$105.97M
Cash & Equivalents
$65.93M
Debt / Equity
0.00×
Net Margin
-140.3%
Shares Outstanding
81.12M sh
Source: 10-K · filed 2026-03-30 · accession 0001104659-26-036494

Short Interest & Short Volume

10.80 days to cover

FINRA reported short interest of 6,641,078 shares in MGTX as of the October 30, 2026 settlement, a 3.2% increase from the prior period — about 10.8 days to cover at its recent average daily volume. On November 20, 2026, 72.7% of MGTX volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)6,641,078 shares as of October 30, 2026
Change vs prior period▲ 3.2%
Days to cover10.80 at avg daily volume of 615,016
Daily short volume (FINRA facilities)72.7% of 245,169 shares on November 20, 2026
5-day average short volume68.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for MGTX, detected from its recent SEC filings · based on capital-structure filings through 2026-11-12.

1 shelf registration

New $100M ATM With BofA · Agent Compensation Up to 3.0%

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with M →
$7.98
52-week range · as of 2026-08-13 $6.62 – $15.35
Market cap
$779.89M
Volume
1M (1.4× avg)
3-mo avg 711.3K
Live data · 2026-11-21 23:59 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed MGTX - Latest Insights

MGTX
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $9.49
Real-time Price: $7.98 info
Change: -$1.51 (-16%) info
Market Cap: $779.89M info
MGTX
Aug 13, 2026, 8:23 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $13.89
Real-time Price: $7.98 info
Change: -$5.91 (-43%) info
Market Cap: $779.89M info
MGTX
Aug 13, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $13.29
Real-time Price: $7.98 info
Change: -$5.31 (-40%) info
Market Cap: $779.89M info
MGTX
Aug 13, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $13.29
Real-time Price: $7.98 info
Change: -$5.31 (-40%) info
Market Cap: $779.89M info
MGTX
Aug 11, 2026, 11:39 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $12.99
Real-time Price: $7.98 info
Change: -$5.01 (-39%) info
Market Cap: $779.89M info
MGTX
Jul 07, 2026, 7:42 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $14.42
Real-time Price: $7.98 info
Change: -$6.44 (-45%) info
Market Cap: $779.89M info
MGTX
Jul 07, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $14.65
Real-time Price: $7.98 info
Change: -$6.67 (-46%) info
Market Cap: $779.89M info
MGTX
May 14, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $9.70
Real-time Price: $7.98 info
Change: -$1.72 (-18%) info
Market Cap: $779.89M info
MGTX
May 14, 2026, 8:06 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.70
Real-time Price: $7.98 info
Change: -$1.72 (-18%) info
Market Cap: $779.89M info
MGTX
Apr 30, 2026, 8:04 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $8.78
Real-time Price: $7.98 info
Change: -$0.800 (-9%) info
Market Cap: $779.89M info
MGTX
Apr 24, 2026, 4:46 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $9.36
Real-time Price: $7.98 info
Change: -$1.38 (-15%) info
Market Cap: $779.89M info
MGTX
Apr 24, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $10.23
Real-time Price: $7.98 info
Change: -$2.25 (-22%) info
Market Cap: $779.89M info
MGTX
Apr 16, 2026, 5:25 PM EDT
Filing Type: 424B5
Importance Score:
8
Price at Filing: $9.36
Real-time Price: $7.98 info
Change: -$1.38 (-15%) info
Market Cap: $779.89M info
MGTX
Apr 16, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $9.36
Real-time Price: $7.98 info
Change: -$1.38 (-15%) info
Market Cap: $779.89M info
MGTX
Apr 16, 2026, 7:47 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $9.70
Real-time Price: $7.98 info
Change: -$1.72 (-18%) info
Market Cap: $779.89M info
MGTX
Apr 16, 2026, 7:16 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $12.05
Real-time Price: $7.98 info
Change: -$4.07 (-34%) info
Market Cap: $779.89M info
MGTX
Apr 16, 2026, 7:09 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $11.40
Real-time Price: $7.98 info
Change: -$3.42 (-30%) info
Market Cap: $779.89M info
MGTX
Apr 16, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $11.40
Real-time Price: $7.98 info
Change: -$3.42 (-30%) info
Market Cap: $779.89M info
MGTX
Mar 30, 2026, 8:15 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $7.62
Real-time Price: $7.98 info
Change: +$0.360 (+5%) info
Market Cap: $779.89M info
MGTX
Mar 30, 2026, 8:13 AM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $7.62
Real-time Price: $7.98 info
Change: +$0.360 (+5%) info
Market Cap: $779.89M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets